Earnings Calendar - Mar 26, 2025
Stay up-to-date with this week's earnings announcements and filter by specific dates. Explore earnings reports for top companies, and discover valuable insights into retained earnings, earnings per share (EPS), revenue, and more.
Dec 13Friday
Dec 14SaturdayNo Events
Dec 15SundayNo Events
Showing earnings announcements on Mar 26, 2025
Name
Company
Market Cap
EPS (Forecast)
EPS (Actual)
Revenue (Forecast)
Revenue (Actual)
Time
Analyst Consensus
Smart Score
Follow
MUMicron$101.15B
xxxxxxxxxxxxx
GMEGameStop$8.81B
xxxxxxxxxxxxx
GOEVCanoo$97.47M
xxxxxxxxxxxxx
IDEXIdeanomics$4.01M
xxxxxxxxxxxxx
IONQIonQ$1.66B
xxxxxxxxxxxxx
BLRXBioline RX Ltd Sponsored ADR$55.00M
xxxxxxxxxxxxx
ATYRaTyr Pharma$144.01M
xxxxxxxxxxxxx
BYDDYBYD Company$95.57B
xxxxxxxxxxxxx
RHRH$5.95B
xxxxxxxxxxxxx
BIOLBiolase$1.94M
xxxxxxxxxxxxx
FIVEFive Below$5.31B
xxxxxxxxxxxxx
SPRUSpruce Power Holding$49.55M
xxxxxxxxxxxxx
SCYXSCYNEXIS$55.27M
xxxxxxxxxxxxx
BEEMBeam Global$77.35M
xxxxxxxxxxxxx
PAYXPaychex$48.60B
xxxxxxxxxxxxx
BTBTBit Digital$424.16M
xxxxxxxxxxxxx
ALRNAileron Therapeutics$59.36M
xxxxxxxxxxxxx
BIORBiora Therapeutics$23.71M
xxxxxxxxxxxxx
INUVInuvo$37.64M
xxxxxxxxxxxxx
VISLVislink Technologies$14.85M
xxxxxxxxxxxxx
TIGRUp Fintech Holding$549.88M
xxxxxxxxxxxxx
ACFNAcorn Energy$24.82M
xxxxxxxxxxxxx
TSHATaysha Gene Therapies$469.32M
xxxxxxxxxxxxx
BRZEBraze$3.61B
xxxxxxxxxxxxx
BGNEBeiGene$21.96B$1.41B
xxxxxxxxxxxxx
EYENEyenovia$41.28M
xxxxxxxxxxxxx
EQEquillium$30.82M
xxxxxxxxxxxxx
DNMRDanimer Scientific$47.47M
xxxxxxxxxxxxx
POLAPolar Power$7.52M
xxxxxxxxxxxxx
ADVMAdverum Biotechnologies$150.39M
xxxxxxxxxxxxx
GOVXGeoVax Labs$24.21M
xxxxxxxxxxxxx
MREOMereo Biopharma Group Plc$658.11M
xxxxxxxxxxxxx
VRNTVerint Systems$1.64B
xxxxxxxxxxxxx
STROSutro Biopharma$368.84M
xxxxxxxxxxxxx
AMLXAmylyx Pharmaceuticals Inc$178.38M
xxxxxxxxxxxxx
PHGEBiomX$17.77M
xxxxxxxxxxxxx
RKDAArcadia Biosciences$3.80M
xxxxxxxxxxxxx
ARTLArtelo Biosciences$3.81M
xxxxxxxxxxxxx
IDXGInterpace Diagnostics Group$6.50M
xxxxxxxxxxxxx
APVOAptevo Therapeutics$3.34M
xxxxxxxxxxxxx
SLGLSol-Gel Technologies$17.27M
xxxxxxxxxxxxx
UPHLUpHealth$3.13M
xxxxxxxxxxxxx
SDIGStronghold Digital Mining$77.86M
xxxxxxxxxxxxx
CXMSprinklr$2.01B
xxxxxxxxxxxxx
SNESSenesTech$1.59M
xxxxxxxxxxxxx
USIOUsio$40.22M
xxxxxxxxxxxxx
DFLIDragonfly Energy Holdings Corp$36.30M
xxxxxxxxxxxxx
CWCOConsolidated Water Co$409.00M
xxxxxxxxxxxxx
FCFranklin Covey Company$514.35M
xxxxxxxxxxxxx
YRDYiren Digital$393.09M
xxxxxxxxxxxxx
PHRPhreesia$1.43B
xxxxxxxxxxxxx
IMABI-MAB$81.64M-$0.12
xxxxxxxxxxxxx
HYMCHycroft Mining Holding$64.14M
xxxxxxxxxxxxx
DRIODarioHealth$28.47M
xxxxxxxxxxxxx
EDAPEDAP TMS$120.22M
xxxxxxxxxxxxx
RPHMReneo Pharmaceuticals$43.79M
xxxxxxxxxxxxx
BOLTBolt Biotherapeutics$23.29M
xxxxxxxxxxxxx
LITBLightInTheBox$68.21M
xxxxxxxxxxxxx
FULH.B. Fuller Company$4.40B
xxxxxxxxxxxxx
IMNMImmunome$959.07M
xxxxxxxxxxxxx
IVAInventiva$121.54M
xxxxxxxxxxxxx
SNDASonida Senior Living, Inc.$492.81M
xxxxxxxxxxxxx
CHCIComstock Homebuilding Companies$81.95M
xxxxxxxxxxxxx
PRPHProphase Labs$46.74M
xxxxxxxxxxxxx
AACGATA Creativity Global$16.94M
xxxxxxxxxxxxx
GFAIGuardforce AI Co$12.28M
xxxxxxxxxxxxx
YHGJYunhong Green CTI$17.59M
xxxxxxxxxxxxx
SRADSportradar Group AG$3.49B
xxxxxxxxxxxxx
ASNSActelis Networks, Inc.$10.17M
xxxxxxxxxxxxx
SHWZMedicine Man Technologies$15.65M
xxxxxxxxxxxxx
TATTTat Techno$174.10M
xxxxxxxxxxxxx
USEGUS Energy$26.65M
xxxxxxxxxxxxx
CGTXCognition Therapeutics$24.08M
xxxxxxxxxxxxx
ACRVAcrivon Therapeutics, Inc.$275.96M
xxxxxxxxxxxxx
MDAISpectral AI$22.71M
xxxxxxxxxxxxx
VRPXVirpax Pharmaceuticals$4.05M
xxxxxxxxxxxxx
DYAIDyadic International$36.55M
xxxxxxxxxxxxx
AVTEAerovate Therapeutics$54.85M
xxxxxxxxxxxxx
EASTEastside Distilling$1.17M
xxxxxxxxxxxxx
RVYLRyvyl$7.23M
xxxxxxxxxxxxx
LOCLLocal Bounti Corporation$20.62M
xxxxxxxxxxxxx
BMTXBM Technologies$38.23M
xxxxxxxxxxxxx
MRAIMarpai$5.63M
xxxxxxxxxxxxx
NTIPNetwork-1 Technologies$35.64M
xxxxxxxxxxxxx
GDEVNexters$506.98M
xxxxxxxxxxxxx
KRKR36Kr Holdings Inc$9.56M
xxxxxxxxxxxxx
LFLYLeafly Holdings, Inc.$4.63M
xxxxxxxxxxxxx
UNFUniFirst$3.38B
xxxxxxxxxxxxx
GBNHFGreenbrook Tms$410.42K
xxxxxxxxxxxxx
LNZALanzaTech Global$306.56M
xxxxxxxxxxxxx
XYFX Financial$233.35M
xxxxxxxxxxxxx
BNRBurning Rock Biotech$36.57M
xxxxxxxxxxxxx
BOSCBOS Better Online Solutions$16.09M
xxxxxxxxxxxxx
OIBRDOi SA$57.69M
xxxxxxxxxxxxx
UGROurban-gro$17.64M
xxxxxxxxxxxxx
TIVCTivic Health Systems$1.77M
xxxxxxxxxxxxx
OLBOLB Group$3.58M
xxxxxxxxxxxxx
SKYHSky Harbour Group$882.72M
xxxxxxxxxxxxx
MPTIM-tron Industries Inc
xxxxxxxxxxxxx
TSSITSS$122.27M
xxxxxxxxxxxxx
Rows:
100

Earnings News

Phreesia (PHR) Improves Healthcare Outcomes and Expects Growing Clientele
Premium
Market News
Phreesia (PHR) Improves Healthcare Outcomes and Expects Growing Clientele
7h ago
Acrivon reports data from ongoing ACR-368 registrational intent Phase 2 study
Premium
The Fly
Acrivon reports data from ongoing ACR-368 registrational intent Phase 2 study
9h ago
Sutro announces data from Phase 1b study of Luvelta in combo with Bevacizumab
Premium
The Fly
Sutro announces data from Phase 1b study of Luvelta in combo with Bevacizumab
10h ago
Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis
Premium
Press Releases
Acrivon Therapeutics Reports Positive Endometrial Cancer Data from Ongoing ACR-368 Registrational Intent Phase 2 Study at ESMO, Advancement of ACR-2316 into Clinic Ahead of Timelines, and Progress on its AP3 Interactome for Proprietary Data Analysis
2d ago
Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
Premium
Press Releases
Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
2d ago

FAQ

When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
    How do earnings affect stock prices?
    A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
      Is it better to buy a stock before or after earnings?
      Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.